Literature DB >> 24333315

The evolution of the regulatory framework for the plasma and plasma-derived medicinal products system in Italy.

Gabriele Calizzani1, Stefania Vaglio2, Fabio Candura1, Samantha Profili1, Monica Lanzoni1, Karen Cristiano3, Maria Rita Tamburrini4, Giuliano Grazzini1, Fabrizio Oleari5.   

Abstract

Mesh：

Substances：

Year:  2013        PMID： 24333315      PMCID： PMC3853985          DOI： 10.2450/2013.003s

Source DB:  PubMed          Journal:  Blood Transfus        ISSN： 1723-2007            Impact factor:   3.443


× No keyword cloud information.
  8 in total

Review 1.  Plasma fractionation issues.

Authors:  Albert Farrugia; Theo Evers; Pierre-Francois Falcou; Thierry Burnouf; Luiz Amorim; Sylvia Thomas
Journal:  Biologicals       Date:  2009-03-16       Impact factor: 1.856

Review 2.  Clinical appropriateness of blood component transfusion: regulatory requirements and standards set by the Scientific Society in Italy.

Authors:  Giuliano Grazzini
Journal:  Blood Transfus       Date:  2008-10       Impact factor: 3.443

3.  West Nile virus in Italy: a further threat to blood safety, a further challenge to the blood system.

Authors:  Giuliano Grazzini; Giancarlo Maria Liumbruno; Simonetta Pupella; Anna Rita Silvestri; Vanda Randi; Nadia Pascarelli; Paolo Zucchelli; Antonino Di Caro; Nadir Spataro; Erika D'Angelo; Vittorio Sambri
Journal:  Blood Transfus       Date:  2008-10       Impact factor: 3.443

Review 4.  Plasma-derived medicinal products in Italy: information sources and flows.

Authors:  Monica Lanzoni; Claudia Biffoli; Fabio Candura; Gabriele Calizzani; Stefania Vaglio; Giuliano Grazzini
Journal:  Blood Transfus       Date:  2013-09       Impact factor: 3.443

Review 5.  Production of plasma-derived medicinal products: ethical implications for blood donation and donors.

Authors:  Carlo Petrini
Journal:  Blood Transfus       Date:  2013-02-21       Impact factor: 3.443

6.  The Dublin Consensus Statement 2011 on vital issues relating to the collection and provision of blood components and plasma-derived medicinal products.

Authors:  B O'Mahony; A Turner
Journal:  Vox Sang       Date:  2011-08-01       Impact factor: 2.144

7.  Convention for the protection of human rights and dignity of the human being with regard to the application of biology and medicine: convention on human rights and biomedicine (adopted by the Committee of Ministers on 19 November 1996). Council of Europe Convention of Biomedicine.

Authors: 
Journal:  Hum Reprod       Date:  1997-09       Impact factor: 6.918

8.  The Chikungunya epidemic in Italy and its repercussion on the blood system.

Authors:  Giancarlo Maria Liumbruno; Deanna Calteri; Kyriakoula Petropulacos; Andrea Mattivi; Claudio Po; Pierluigi Macini; Ivana Tomasini; Paolo Zucchelli; Anna Rita Silvestri; Vittorio Sambri; Simonetta Pupella; Liviana Catalano; Vanessa Piccinini; Gabriele Calizzani; Giuliano Grazzini
Journal:  Blood Transfus       Date:  2008-10       Impact factor: 3.443
  8 in total
  6 in total

Review 1.  Plasma and plasma-derived medicinal product self-sufficiency: the Italian case.

Authors:  Gabriele Calizzani; Samantha Profili; Fabio Candura; Monica Lanzoni; Stefania Vaglio; Livia Cannata; Liviana Catalano; Rosa Chianese; Giancarlo M Liumbruno; Giuliano Grazzini
Journal:  Blood Transfus       Date:  2013-09       Impact factor: 3.443

Review 2.  Plasma-derived medicinal products in Italy: information sources and flows.

Authors:  Monica Lanzoni; Claudia Biffoli; Fabio Candura; Gabriele Calizzani; Stefania Vaglio; Giuliano Grazzini
Journal:  Blood Transfus       Date:  2013-09       Impact factor: 3.443

Review 3.  Present and future challenges in the treatment of haemophilia: the patient's perspective.

Authors:  Romano Arcieri; Angelo C Molinari; Stefania Farace; Giuseppe Mazza; Alberto Garnero; Gabriele Calizzani; Paola Giordano; Emily Oliovecchio; Lorenzo Mantovani; Lamberto Manzoli; Paul Giangrande
Journal:  Blood Transfus       Date:  2013-09       Impact factor: 3.443

Review 4.  The demand for factor VIII and for factor IX and the toll fractionation product surplus management.

Authors:  Gabriele Calizzani; Samantha Profili; Fabio Candura; Monica Lanzoni; Stefania Vaglio; Livia Cannata; Giancarlo M Liumbruno; Massimo Franchini; Pier Mannuccio Mannucci; Giuliano Grazzini
Journal:  Blood Transfus       Date:  2013-09       Impact factor: 3.443

5.  Plasma-derived medicinal products: demand and clinical use.

Authors:  Giuliano Grazzini; Pier Mannuccio Mannucci; Fabrizio Oleari
Journal:  Blood Transfus       Date:  2013-09       Impact factor: 3.443

6.  Use of fresh-frozen plasma in 2012 at the Fondazione Ca' Granda Hospital of Milan: assessment of appropriateness using record linkage techniques applied to data routinely recorded in various hospital information systems.

Authors:  Monica Lanzoni; Barbara Olivero; Andrea Artoni; Maurizio Marconi; Elisabetta Raspollini; Silvana Castaldi
Journal:  Blood Transfus       Date:  2017-06-19       Impact factor: 3.443
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.